Literature DB >> 11171118

A member of the nuclear factor-1 family is involved in the pituitary repression of the human placental growth hormone genes.

L D Norquay1, Y Jin, R M Surabhi, R D Gietz, N Tanese, P A Cattini.   

Abstract

The human growth hormone (GH) gene family consists of five tandemly arranged and highly related genes, including the chorionic somatomammotropins (CSs), at a single locus on chromosome 17. Despite striking homologies in promoter and flanking DNA sequences, the genes within this locus have different tissue-specific patterns of expression: GH-N is expressed almost exclusively in the somatotrophs of the anterior pituitary; the remaining genes, including CS-A, are expressed in placental syncytiotrophoblast. Previously we proposed that active repression of the placental gene promoters in pituitary GC cells is mediated by upstream 'P' sequences and, specifically, a 263 bp region containing two 'P' sequence elements (PSE-A and PSE-B) and corresponding factors (PSF-A and PSF-B). We have now examined the possibility that PSF-A and PSF-B are members of the nuclear factor (NF)-1 family. Transcripts of NF-1A, NF-1C and NF-1X, but not of NF-1B, were readily detected in GC cells. High-affinity binding of NF-1 to PSE-B, but not to PSE-A, was confirmed by competition of DNA-protein interactions by using NF-1 DNA elements and antibodies. Functionally, a NF-1 element was able to substitute for PSE-B as a promoter-specific repressor in GC cells after gene transfer. However, there was a difference in the magnitude of repression exerted by the NF-1 and PSF-B elements on the CS-A promoter and, with the use of mutations, this difference was shown to be consistent with variations in NF-1-binding sequences. These results indicate that PSF-B, but not PSF-A, is a member of the NF-1 family, which participates in the PSF complex and in the repression of the CS-A promoter in pituitary GC cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171118      PMCID: PMC1221667          DOI: 10.1042/0264-6021:3540387

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Identification of the transcriptional repression domain of nuclear factor 1-A.

Authors:  S Osada; T Ikeda; M Xu; T Nishihara; M Imagawa
Journal:  Biochem Biophys Res Commun       Date:  1997-09-29       Impact factor: 3.575

2.  The rat growth hormone and human cellular retinol binding protein 1 genes share homologous NF1-like binding sites that exert either positive or negative influences on gene expression in vitro.

Authors:  S Leclerc; W Eskild; S L Guérin
Journal:  DNA Cell Biol       Date:  1997-08       Impact factor: 3.311

3.  Transcription factor nuclear factor I proteins form stable homo- and heterodimers.

Authors:  U Kruse; A E Sippel
Journal:  FEBS Lett       Date:  1994-07-04       Impact factor: 4.124

4.  Histone H1 isoforms purified from rat liver bind nonspecifically to the nuclear factor 1 recognition sequence and serve as generalized transcriptional repressors.

Authors:  B Gao; H Jaffe; G Kunos
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

5.  Identification of DNA binding-site preferences for nuclear factor I-A.

Authors:  S Osada; S Daimon; T Nishihara; M Imagawa
Journal:  FEBS Lett       Date:  1996-07-15       Impact factor: 4.124

6.  NFI/X proteins: a class of NFI family of transcription factors with positive and negative regulatory domains.

Authors:  G Nebl; A C Cato
Journal:  Cell Mol Biol Res       Date:  1995

7.  The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation.

Authors:  H Xiao; J T Lis; H Xiao; J Greenblatt; J D Friesen
Journal:  Nucleic Acids Res       Date:  1994-06-11       Impact factor: 16.971

8.  NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing.

Authors:  Y Liu; H U Bernard; D Apt
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

9.  "Repair' of the chorionic somatomammotropin-A "enhancer' region reveals a novel functional element in the chorionic somatomammotropin-B enhancer.

Authors:  A Lytras; R M Surabhi; J F Zhang; Y Jin; P A Cattini
Journal:  Mol Cell Endocrinol       Date:  1996-05-17       Impact factor: 4.102

10.  Nuclease sensitivity of the human growth hormone-chorionic somatomammotropin locus in pituitary and placenta suggest different mechanisms for tissue-specific regulation.

Authors:  B E Nickel; P A Cattini
Journal:  Mol Cell Endocrinol       Date:  1996-04-19       Impact factor: 4.102

View more
  5 in total

1.  Identification and characterization of a prostate-specific androgen-independent protein-binding site in the probasin promoter.

Authors:  Lillian H Y Yeung; Jason T Read; Pernille Sorenson; Colleen C Nelson; William Jia; Paul S Rennie
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

2.  Insulin represses transcription of the thyroid stimulating hormone beta-subunit gene through increased recruitment of nuclear factor I.

Authors:  Kee Kwang Kim; Key Sun Park; Seok Bean Song; Kyoon Eon Kim
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

Review 3.  Placental growth hormones.

Authors:  Marie-Christine Lacroix; Jean Guibourdenche; Jean-Louis Frendo; Guillaume Pidoux; Danièle Evain-Brion
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

4.  CCAAT-enhancer-binding protein β (C/EBPβ) and downstream human placental growth hormone genes are targets for dysregulation in pregnancies complicated by maternal obesity.

Authors:  Hana Vakili; Yan Jin; Savas Menticoglou; Peter A Cattini
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

5.  Expression of Placental Members of the Human Growth Hormone Gene Family Is Increased in Response to Sequential Inhibition of DNA Methylation and Histone Deacetylation.

Authors:  Esha Ganguly; Margaret E Bock; Peter A Cattini
Journal:  Biores Open Access       Date:  2015-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.